Huntington National Bank Bristol Myers Squibb CO Transaction History

Huntington National Bank

  • $13.5 Billion
  • Q3 2024

A detailed history of Huntington National Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Huntington National Bank holds 164,542 shares of BMY stock, worth $9.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
164,542
Previous 166,249 1.03%
Holding current value
$9.5 Million
Previous $6.9 Million 23.33%
% of portfolio
0.06%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
SELL
$39.66 - $51.75 $67,699 - $88,337
-1,707 Reduced 1.03%
164,542 $8.52 Million
Q2 2024

Aug 08, 2024
SELL
$40.25 - $52.99 $590,910 - $777,946
-14,681 Reduced 8.11%
166,249 $6.9 Million
Q1 2024

May 03, 2024
SELL
$47.98 - $54.4 $1.08 Million - $1.22 Million
-22,411 Reduced 11.02%
180,930 $9.81 Million
Q4 2023

Feb 07, 2024
SELL
$48.48 - $57.85 $722,885 - $862,601
-14,911 Reduced 6.83%
203,341 $10.4 Million
Q3 2023

Nov 08, 2023
SELL
$57.89 - $64.73 $677,891 - $757,988
-11,710 Reduced 5.09%
218,252 $12.7 Million
Q2 2023

Aug 11, 2023
BUY
$63.71 - $70.74 $114,423 - $127,049
1,796 Added 0.79%
229,962 $14.7 Million
Q1 2023

May 10, 2023
SELL
$65.71 - $74.53 $1.29 Million - $1.46 Million
-19,578 Reduced 7.9%
228,166 $15.8 Million
Q4 2022

Feb 09, 2023
SELL
$68.48 - $81.09 $365,340 - $432,615
-5,335 Reduced 2.11%
247,744 $17.8 Million
Q3 2022

Nov 07, 2022
SELL
$0.13 - $76.84 $727 - $429,842
-5,594 Reduced 2.16%
253,079 $18 Million
Q2 2022

Aug 09, 2022
SELL
$72.62 - $79.98 $247,271 - $272,331
-3,405 Reduced 1.3%
258,673 $19.9 Million
Q1 2022

May 10, 2022
SELL
$61.48 - $73.72 $366,482 - $439,444
-5,961 Reduced 2.22%
262,078 $19.1 Million
Q4 2021

Jan 21, 2022
SELL
$53.63 - $62.52 $601,835 - $701,599
-11,222 Reduced 4.02%
268,039 $16.7 Million
Q3 2021

Oct 28, 2021
SELL
$59.17 - $69.31 $319,873 - $374,689
-5,406 Reduced 1.9%
279,261 $16.5 Million
Q2 2021

Jul 30, 2021
BUY
$61.91 - $67.42 $1.38 Million - $1.5 Million
22,211 Added 8.46%
284,667 $19 Million
Q1 2021

Apr 12, 2021
SELL
$59.34 - $66.74 $518,928 - $583,641
-8,745 Reduced 3.22%
262,456 $16.6 Million
Q4 2020

Jan 11, 2021
SELL
$57.74 - $65.43 $506,553 - $574,017
-8,773 Reduced 3.13%
271,201 $16.8 Million
Q3 2020

Oct 30, 2020
SELL
$57.43 - $63.64 $441,464 - $489,200
-7,687 Reduced 2.67%
279,974 $16.9 Million
Q2 2020

Jul 30, 2020
SELL
$54.82 - $64.09 $970,697 - $1.13 Million
-17,707 Reduced 5.8%
287,661 $16.9 Million
Q1 2020

Apr 27, 2020
SELL
$46.4 - $67.43 $578,886 - $841,256
-12,476 Reduced 3.93%
305,368 $17 Million
Q4 2019

Jan 17, 2020
BUY
$49.21 - $64.19 $147,285 - $192,120
2,993 Added 0.95%
317,844 $20.4 Million
Q3 2019

Nov 01, 2019
SELL
$42.77 - $50.71 $869,899 - $1.03 Million
-20,339 Reduced 6.07%
314,851 $16 Million
Q2 2019

Jul 23, 2019
SELL
$44.62 - $49.34 $1.41 Million - $1.56 Million
-31,548 Reduced 8.6%
335,190 $15.2 Million
Q1 2019

Apr 09, 2019
SELL
$45.12 - $53.8 $981,901 - $1.17 Million
-21,762 Reduced 5.6%
366,738 $17.5 Million
Q4 2018

Jan 28, 2019
SELL
$48.76 - $63.23 $1.69 Million - $2.19 Million
-34,683 Reduced 8.2%
388,500 $20.2 Million
Q3 2018

Oct 18, 2018
SELL
$55.19 - $62.25 $1.66 Million - $1.87 Million
-30,053 Reduced 6.63%
423,183 $26.3 Million
Q2 2018

Jul 19, 2018
SELL
$50.53 - $62.98 $2.69 Million - $3.35 Million
-53,149 Reduced 10.5%
453,236 $25.1 Million
Q1 2018

Apr 30, 2018
SELL
$59.92 - $68.98 $2.08 Million - $2.4 Million
-34,764 Reduced 6.42%
506,385 $32 Million
Q4 2017

Feb 02, 2018
SELL
$59.94 - $65.35 $2.82 Million - $3.08 Million
-47,076 Reduced 8.0%
541,149 $33.2 Million
Q3 2017

Oct 24, 2017
BUY
$55.23 - $63.74 $32.5 Million - $37.5 Million
588,225
588,225 $37.5 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email